IRadimed Corporation (IRMD)
NASDAQ·Healthcare·Medical - Devices
$83.75
-5.98%
Mkt Cap $1.14B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 10, 2026 | $21.60M | $22.69M | +5.06% | $0.49 | $0.54 | +10.20% | — | — |
| Q4 2025 Nov 3, 2025 | $21.60M | $21.20M | -1.83% | $0.48 | $0.47 | -2.08% | — | — |
| Q3 2025 Aug 1, 2025 | $20.50M | $20.41M | -0.43% | $0.45 | $0.49 | +8.89% | — | — |
| Q2 2025 May 5, 2025 | $19.33M | $19.51M | +0.92% | $0.43 | $0.42 | -2.33% | — | — |
| Q1 2025 Feb 13, 2025 | $19.20M | $19.39M | +0.99% | $0.45 | $0.44 | -2.22% | — | — |
| Q4 2024 Oct 31, 2024 | $18.94M | $18.33M | -3.24% | $0.39 | $0.43 | +10.26% | — | — |
| Q3 2024 Aug 1, 2024 | $17.65M | $17.93M | +1.58% | $0.37 | $0.42 | +13.51% | — | — |
| Q2 2024 May 2, 2024 | $17.13M | $17.60M | +2.73% | $0.34 | $0.36 | +5.88% | — | — |
| Q1 2024 Feb 8, 2024 | $17.33M | $17.45M | +0.70% | $0.40 | $0.39 | -2.50% | — | — |
| Q4 2023 Nov 3, 2023 | $16.17M | $16.50M | +2.07% | $0.36 | $0.43 | +19.44% | — | — |
| Q3 2023 Aug 3, 2023 | $15.65M | $16.13M | +3.07% | $0.31 | $0.36 | +16.13% | — | — |
| Q2 2023 May 4, 2023 | $14.77M | $15.48M | +4.77% | $0.28 | $0.30 | +7.14% | — | — |
| Q1 2023 Feb 2, 2023 | $14.90M | $14.86M | -0.24% | $0.30 | $0.32 | +6.67% | — | — |
| Q4 2022 Nov 3, 2022 | $13.19M | $13.41M | +1.67% | $0.25 | $0.29 | +16.00% | — | — |
| Q3 2022 Jul 29, 2022 | $12.60M | $12.72M | +0.96% | $0.24 | $0.26 | +8.33% | — | — |
| Q2 2022 Apr 29, 2022 | $12.21M | $12.31M | +0.81% | $0.21 | $0.22 | +4.76% | — | — |
| Q1 2022 Feb 4, 2022 | $11.65M | $11.87M | +1.91% | $0.21 | $0.33 | +57.14% | — | — |
| Q4 2021 Oct 29, 2021 | $10.40M | $10.91M | +4.88% | $0.17 | $0.23 | +35.29% | — | — |
| Q3 2021 Jul 30, 2021 | $9.81M | $9.81M | +0.00% | $0.10 | $0.14 | +40.00% | — | — |
| Q2 2021 Apr 30, 2021 | $6.46M | $9.22M | +42.86% | $0.10 | $0.13 | +30.00% | — | — |